The Novel HLA-C*07:1088 Allele Characterised by Two Different Sequencing-Based Typing Techniques
Michaël Pérès1, Adèle Dhuyser1,2, Thomas Morel1
1HLA and Histocompatibility Laboratory, CHRU de Nancy, Vandœuvre-lès-Nancy, France.
HLA
|May 16, 2025
Summary
A new human leukocyte antigen (HLA) allele, HLA-C*07:1088, has been identified. This novel HLA allele differs from the known HLA-C*07:01:01:01 by a single nucleotide substitution.
Area of Science:
- Immunogenetics
- Molecular biology
- Human leukocyte antigen (HLA) research
Background:
- The human leukocyte antigen (HLA) system plays a critical role in immune response.
- Genetic variations in HLA alleles contribute to diverse immune functions and disease susceptibility.
- Accurate characterization of novel HLA alleles is essential for immunological studies and clinical applications.
Purpose of the Study:
- To report the discovery and initial characterization of a novel HLA allele.
- To detail the specific genetic difference between the novel allele and a known reference allele.
Main Methods:
- Sequence analysis of the novel allele.
- Comparison of the novel allele's sequence with existing HLA allele databases.
- Identification of nucleotide substitutions and their locations.
Main Results:
- A novel HLA allele, designated HLA-C*07:1088, was identified.
- This new allele differs from HLA-C*07:01:01:01 by a single nucleotide substitution.
- The substitution is non-synonymous and located in exon 3 of the HLA-C gene.
Conclusions:
- The identification of HLA-C*07:1088 expands the known repertoire of HLA-C alleles.
- This single nucleotide substitution represents a specific genetic marker for this novel allele.
- Further studies are warranted to understand the potential functional and clinical implications of HLA-C*07:1088.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
13.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.7K
Genome-wide Association Studies-GWAS
12.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.2K


